ULBP2 antibody

CAT: 0710-FNab09250Size: 100 µgDry Ice: NoHazardous: No
CAT#:0710-FNab09250Size:100 µg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Background
Ligand for the KLRK1/NKG2D receptor, together with at least ULBP1 and ULBP3. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to KLRK1/NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. In CMV infected cells, interacts with soluble CMV glycoprotein UL16. The interaction with UL16 blocked the interaction with the KLRK1/NKG2D receptor, providing a mechanism by which CMV infected cells might escape the immune system. UL16 also causes ULBP2 to be retained in the ER and cis-Golgi apparatus so that it does not reach the cell surface.
Synonyms
UL16-binding protein 2|ALCAN-alpha|NKG2D ligand 2 (N2DL-2, NKG2DL2) |Retinoic acid early transcript 1H|ULBP2|N2DL2|RAET1H
Gene ID
80328
UniProt
Q9BZM5
Host
Rabbit
Reactivity
Human
Immunogen
UL16 binding protein 2
Target
ULBP2
Clonality
Polyclonal
Isotype
IgG
Applications
ELISA, WB
Field of Research
Cancer
Purification
Immunogen affinity purified
Dilution
WB: 1:500-1:5000
Purity
≥95% as determined by SDS-PAGE
Form
Liquid
Molecular Weight
30-35 kDa
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
Tested Applications
ELISA, WB

Popular Products